Cargando…
Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with fr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126704/ https://www.ncbi.nlm.nih.gov/pubmed/34012282 http://dx.doi.org/10.2147/CCID.S284435 |
_version_ | 1783693817708281856 |
---|---|
author | Cardoso, Camila O Tolentino, Seila Gratieri, Tais Cunha-Filho, Marcilio Lopez, Renata F V Gelfuso, Guilherme M |
author_facet | Cardoso, Camila O Tolentino, Seila Gratieri, Tais Cunha-Filho, Marcilio Lopez, Renata F V Gelfuso, Guilherme M |
author_sort | Cardoso, Camila O |
collection | PubMed |
description | Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with frequent use, and low drug absorption to the site of action, which limits the efficacy. The most recent research points out that different formulation technology could circumvent the aforementioned flaws. Such technology includes incorporation of drugs in rigid or deformable nanoparticles, strategies involving physical, energetical and mechanical techniques, such as iontophoresis, sonophoresis, microneedling, and the use of solid effervescent granules to be hydrated at the moment of application in the scalp. In this paper, the progress of current research on topical formulations dedicated to the treatment of alopecia is reviewed and discussed. |
format | Online Article Text |
id | pubmed-8126704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81267042021-05-18 Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence Cardoso, Camila O Tolentino, Seila Gratieri, Tais Cunha-Filho, Marcilio Lopez, Renata F V Gelfuso, Guilherme M Clin Cosmet Investig Dermatol Review Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with frequent use, and low drug absorption to the site of action, which limits the efficacy. The most recent research points out that different formulation technology could circumvent the aforementioned flaws. Such technology includes incorporation of drugs in rigid or deformable nanoparticles, strategies involving physical, energetical and mechanical techniques, such as iontophoresis, sonophoresis, microneedling, and the use of solid effervescent granules to be hydrated at the moment of application in the scalp. In this paper, the progress of current research on topical formulations dedicated to the treatment of alopecia is reviewed and discussed. Dove 2021-05-12 /pmc/articles/PMC8126704/ /pubmed/34012282 http://dx.doi.org/10.2147/CCID.S284435 Text en © 2021 Cardoso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Cardoso, Camila O Tolentino, Seila Gratieri, Tais Cunha-Filho, Marcilio Lopez, Renata F V Gelfuso, Guilherme M Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title | Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title_full | Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title_fullStr | Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title_full_unstemmed | Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title_short | Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence |
title_sort | topical treatment for scarring and non-scarring alopecia: an overview of the current evidence |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126704/ https://www.ncbi.nlm.nih.gov/pubmed/34012282 http://dx.doi.org/10.2147/CCID.S284435 |
work_keys_str_mv | AT cardosocamilao topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence AT tolentinoseila topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence AT gratieritais topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence AT cunhafilhomarcilio topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence AT lopezrenatafv topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence AT gelfusoguilhermem topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence |